Johnson Johnson completes first cases with OTTAVA robotic surgical system

INSUBCONTINENT EXCLUSIVE:
While J-J has kept its Ottava robot under wraps, it said the system offers surgical teams the ability to adapt to clinical workflows and
individual patient needs
| Source: Johnson - JohnsonJohnson - Johnson MedTech this week announced that it has completed the first cases in the clinical trial for its
OTTAVA Robotic Surgical System
The cases mark the first clinical experience with the OTTAVA System, it said.We are proud to reach this important milestone in our robotic
surgery program, said Hani Abouhalka, the company group chairman of surgery at Johnson - Johnson MedTech.OTTAVA is a key innovation in our
portfolio of advanced surgical technologies all of which are designed to transform the surgical experiences across all surgery, he added
Our people work side-by-side with surgical teams in ORs [operating rooms] around the world every day to raise the standard of care for
patients and deliver whats next in surgery.Johnson - Johnson MedTech is a Warsaw, Ind.-based unit of Johnson - Johnson (J-J), which has more
than 100 years of experience in medicine and surgical technology
The company said its portfolio includes robotics, wound closure, adjunctive hemostats, surgical stapling and instruments, and digital
systems.OTTAVA addresses surgical robotics shortcomingsThe United States Food and Drug Administration (FDA) granted OTTAVA an
investigational device exemption in late 2024
Johnson - Johnson MedTech said it designed the system to advance clinical innovation in general surgery, a significant part of its broader
surgery business.J-J described OTTAVA as a multi-specialty soft-tissue surgery robot, supporting a broad range of procedures across patient
anatomy and surgical specialties, including the most complex surgeries that require a multi-quadrant approach
The systems unified architecture, surgical instrumentation built on J-Js Ethicon experience, and a planned connection to the Polyphonic
digital ecosystem are intended to meet the needs of each patients care and each surgeons clinical approach, the company asserted.Johnson -
Johnson MedTech first shared details about OTTAVA about four years ago
Since then, it has been relatively quiet
In October 2021, the company pushed back the platforms development timeline by about two years, citing multiple factors.OTTAVAs initial
design included six robotic arms
In November 2023, a J-J update included changes, including four arms to be available on demand.Register now so you don't miss out!Johnson -
Johnson MedTech preps for next stepsDr
Erik Wilson is the chief of minimally invasive and elective general surgery at the University of Texas Health Houston and the lead
investigator for the clinical study
He performed a Roux-en-Y gastric-bypass surgery using the OTTAVA Robotic Surgical System at Memorial Hermann-Texas Medical Center.Surgical
robotics is at the forefront of innovation in minimally invasive surgery, said Wilson
I am proud to have performed the first clinical study cases with OTTAVA and potentially help advance the standard in surgical
robotics.Johnson - Johnson MedTech plans to use data from this trial aims to support the surgical systems ability to perform a variety of
procedures
Upon completion of the study, the company plans to submit the OTTAVA system for De Novo authorization in the United States J-J said it will
target an indication covering multiple procedures in general surgery within the upper abdomen
These include gastric bypass, gastric sleeve, small bowel resection, and hiatal hernia repair.As a company operating at the intersection of
biology and technology, clinical evidence generation is the core of our innovation programs to advance surgical technology for patients,
said Peter Schulam M.D., Ph.D., and chief scientific officer at Johnson - Johnson MedTech
Through this clinical study, we are proud to be partnering with surgeons to gather evidence and support the ongoing pursuit of scientific
study for the advancement of robotic-assisted minimally invasive surgery.The OTTAVA robotic system is under development and is not yet
authorized to be marketed or sold in any market, noted J-J.The post Johnson - Johnson completes first cases with OTTAVA robotic surgical
system appeared first on The Robot Report.